Polyethylene glycol modification of serpins improves therapeutic potential.
Mast
A E
AE
Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710.
Salvesen
G
G
Brucato
F H
FH
Schnebli
H P
HP
Pizzo
S V
SV
D000805:Angiotensin III / Q000493:pharmacokinetics; D000818:Animals; D006207:Half-Life; D007457:Iodine Radioisotopes; D007700:Kinetics; D051379:Mice; D010084:Oxidation-Reduction; D011092:Polyethylene Glycols / Q000494:pharmacology*; D015843:Serpins / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000627:therapeutic use; D000514:alpha 1-Antichymotrypsin / Q000494:pharmacology; D000515:alpha 1-Antitrypsin / Q000494:pharmacology
D007457:Iodine Radioisotopes; D015843:Serpins; D000514:alpha 1-Antichymotrypsin; D000515:alpha 1-Antitrypsin; D000805:Angiotensin III; D011092:Polyethylene Glycols